FOXP3 and colorectal carcinoma: Looking at the TCGA datasets of CRC patients, it was shown that increased expression of Treg-specific transcription factor FoxP3 (Figure 7A) or anti-inflammatory IL-10 (Figure 7B) resulted in an increase in CRC 5-year patient survival.